BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17714437)

  • 1. Intracellular trafficking of Pseudomonas ExoS, a type III cytotoxin.
    Deng Q; Zhang Y; Barbieri JT
    Traffic; 2007 Oct; 8(10):1331-45. PubMed ID: 17714437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells.
    Zhang Y; Barbieri JT
    Infect Immun; 2005 Dec; 73(12):7938-45. PubMed ID: 16299285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.
    Henriksson ML; Rosqvist R; Telepnev M; Wolf-Watz H; Hallberg B
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):217-22. PubMed ID: 10727422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa ExoS and ExoT.
    Barbieri JT; Sun J
    Rev Physiol Biochem Pharmacol; 2004; 152():79-92. PubMed ID: 15375697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles.
    Zhang Y; Deng Q; Barbieri JT
    J Biol Chem; 2007 Apr; 282(17):13022-32. PubMed ID: 17311921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-ribosylation of cyclophilin A by Pseudomonas aeruginosa exoenzyme S.
    DiNovo AA; Schey KL; Vachon WS; McGuffie EM; Olson JC; Vincent TS
    Biochemistry; 2006 Apr; 45(14):4664-73. PubMed ID: 16584201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.
    Barbieri JT
    Int J Med Microbiol; 2000 Oct; 290(4-5):381-7. PubMed ID: 11111915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S.
    Maresso AW; Riese MJ; Barbieri JT
    Biochemistry; 2003 Dec; 42(48):14249-57. PubMed ID: 14640693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exoenzyme S ADP-ribosylates Rab5 effector sites to uncouple intracellular trafficking.
    Simon NC; Barbieri JT
    Infect Immun; 2014 Jan; 82(1):21-8. PubMed ID: 24101692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoS.
    Zhang Y; Deng Q; Porath JA; Williams CL; Pederson-Gulrud KJ; Barbieri JT
    Cell Microbiol; 2007 Sep; 9(9):2192-201. PubMed ID: 17490406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of exoenzyme S residues that mediate the interaction with 14-3-3 and its biological activity.
    Yasmin L; Jansson AL; Panahandeh T; Palmer RH; Francis MS; Hallberg B
    FEBS J; 2006 Feb; 273(3):638-46. PubMed ID: 16420486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
    Maresso AW; Baldwin MR; Barbieri JT
    J Biol Chem; 2004 Sep; 279(37):38402-8. PubMed ID: 15252013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.
    Henriksson ML; Sundin C; Jansson AL; Forsberg A; Palmer RH; Hallberg B
    Biochem J; 2002 Nov; 367(Pt 3):617-28. PubMed ID: 12132999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells.
    Krall R; Zhang Y; Barbieri JT
    J Biol Chem; 2004 Jan; 279(4):2747-53. PubMed ID: 14597627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
    Maresso AW; Deng Q; Pereckas MS; Wakim BT; Barbieri JT
    Cell Microbiol; 2007 Jan; 9(1):97-105. PubMed ID: 16889625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN.
    Sundin C; Thelaus J; Bröms JE; Forsberg A
    Microb Pathog; 2004 Dec; 37(6):313-22. PubMed ID: 15619427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins.
    Pederson KJ; Krall R; Riese MJ; Barbieri JT
    Mol Microbiol; 2002 Dec; 46(5):1381-90. PubMed ID: 12453223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Pseudomonas aeruginosa type III effectors in disease.
    Engel J; Balachandran P
    Curr Opin Microbiol; 2009 Feb; 12(1):61-6. PubMed ID: 19168385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.
    Riese MJ; Goehring UM; Ehrmantraut ME; Moss J; Barbieri JT; Aktories K; Schmidt G
    J Biol Chem; 2002 Apr; 277(14):12082-8. PubMed ID: 11821389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and purification of two recombinant forms of the type-III cytotoxin, Pseudomonas aeruginosa ExoS.
    Maresso AW; Barbieri JT
    Protein Expr Purif; 2002 Dec; 26(3):432-7. PubMed ID: 12460767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.